JCB, Volume 14, Number 4, 2008 Editorial Vol.14 No. 4 (2008) Continuing education in biotechnology Yali Friedman   Article Vol.14 No. 4 (2008) Can compliance help marketing and business development? John Avellanet In many FDA-regulated companies, the marketing and business development departments have a quietly antagonistic relationship with their quality and regulatory affairs c Article Vol.14 No. 4 (2008) Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiers Laura Heinonen The risks faced by biopharmaceutical companies during the process of drug development are multifaceted and complicated. Furthermore, resource intensiveness and the long Article Vol.14 No. 4 (2008) Got value? Determine it. Demonstrate it. Communicate it. Realise it Mitch DeKoven Many healthcare systems are in crisis due to rising costs, rising demand and inadequate funding. Consequently, healthcare decision makers are increasingly demanding tha Article Vol.14 No. 4 (2008) Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development – Commonalities and differences in portfolio management practice Kerstin M Bode-Greuel The concept of portfolio management has been widely used in the pharmaceutical industry. It is used to evaluate the commercial value and the risk structure of developme From the Classroom Vol.14 No. 4 (2008) Open content textbooks: Educating the next generation of bioentrepreneurs in developing economies Arlen D Meyers Bioclusters, formal and informal networks devoted to the commercial development of life science invention and discoveries, are growing throughout the world, including m Legal and Regulatory Updates Vol.14 No. 4 (2008) Legal and regulatory update Gerry Kamstra   Book Review Vol.14 No. 4 (2008) Book Review: The Regulatory Challenge of Biotechnology John Avellanet The Regulatory Challenge of BiotechnologyHans SomsenEdward Elgar Publishing, Cheltenham, UK;ISBN: 978 1 84542 489 3; 2007; 265pp; hardback Book Review Vol.14 No. 4 (2008) Book Review: Intellectual Property and Biotechnology: Biological Inventions Stefan M Miller Intellectual Property and Biotechnology: Biological InventionsMatthew RimmerEdward Elgar Publishing Limited, Cheltenham, UK and Northampton, MA, USA;ISBN 978 18454294 Book Review Vol.14 No. 4 (2008) Book Review: Commercializing Successful Biomedical Technologies Arlen D Meyers Commercializing Successful Biomedical TechnologiesShreefal S. MehtaCambridge University Press, Cambridge, UK;ISBN 978 0 521 87098 6; 2008; 335pp; hardback Book Review Vol.14 No. 4 (2008) Book Review: Enterprise for Life Scientists: Developing Innovation and Entrepreneurship in the Biosciences Arlen D Meyers Enterprise for Life Scientists: Developing Innovation and Entrepreneurship in the BiosciencesDavid Adams and John Sparrow (eds.)Scion Publishing Ltd, Bloxham, UK;ISBN Book Review Vol.14 No. 4 (2008) Best Practices in Biotechnology Business Development Hans-Erik Hamid Lydecker Best Practices in Biotechnology Business DevelopmentYali FriedmanLogos Press, Washington, DC;ISBN: 978 0 9734676 0 4; 2008; 186pp Book Review Vol.14 No. 4 (2008) Genetic Glass Ceilings: Transgenics for Crop Biodiversity Drew L Kershen Genetic Glass Ceilings: Transgenics for Crop BiodiversityJonathan GresselJohns Hopkins Press, Baltimore;ISBN: 978 0 8018 8719 2; 2008; 488pp; hardback Book Review Vol.14 No. 4 (2008) Biotechnology and the Law Edward L Korwek Biotechnology and the LawHugh B. Wellons, Eileen Smith Ewing, Robert F. Copple, William N. Wofford and Erika King Lietzan (eds)ABA Publishing, Chicago, IL;ISBN: 978 1 Book Review Vol.14 No. 4 (2008) Welcome to Biotech Nation James Rogers Welcome to Biotech NationMoira A. Gunn, PhDAMACOM, New York, NY;ISBN: 978 0814409237; 2007; 258pp; hardback
